BioLife Solutions Awarded Three New Patents for Cell and Gene Therapy Bioproduction Tools

B

ioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, announced three new patents for bioproduction tools related to the 2019 acquisitions of Astero Bio and SAVSU Technologies. The new patents awarded to BioLife include:

United States Patent Contents Rack for Use in Insulated Storage Containers

This patent covers the key technologies used in the -80ยฐC dry ice evo smart shipping container, currently in use by Novartis to transport the AveXis ZOLGENSMA gene therapy. The evo platform was acquired from SAVSU Technologies in August 2019.

Japan Patent Systems, Devices, and Methods for Automated Sample Thawing

This patent covers core technologies used in the ThawSTAR automated, water-free thaw products acquired from Astero Bio in April 2019.

United States Patent Biologic Stability, Delivery Logistics and Administration of Time and/or Temperature Sensitive Biologic Based Materials

This patent covers core features in the evo.is cloud application that enables real-time tracking and monitoring of high-value shipments of cell and gene therapies.

Mike Rice, BioLife Solutions CEO, remarked, We have a remarkably strong team of inventors who are experts in the fields of cryopreservation, storage and transport, and thawing of biologic material. Our portfolio now includes a synergistic family of risk-mitigating bioproduction tools, including our CryoStor and HypoThermosol biopreservation media, ThawSTAR automated, water-free thawing products, evo platform of smart, cloud-connected shipping containers and the evo.is cloud app, and Custom Biogenic Systems high capacity freezers, racks and accessories. We look forward to providing a continuous stream of innovative solutions to the high growth cell and gene therapy market.

โœ”๏ธ BioLife Solutions Awarded Three New Patents for Cell and Gene Therapy Bioproduction Tools

๐Ÿ“ Post your comments

๐Ÿ’• Found this article helpful? Spread the word and support us!